BMY · Congress trades
See corporate insider trades for BMY →
Trades by members of Congress
| Member | Party | Owner | Ticker | Asset | Type | Amount range | Traded | Disclosed | Delay | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mike Kelly Rep | R-PA | Spouse | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sale | $15.0K – $50.0K | 2026-05-07 | 2026-06-11 | 35d | PDF↗ |
| Gilbert Ray Cisneros, Jr. Rep | D-CA | Self | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Purchase | $1.0K – $15.0K | 2025-12-19 | 2026-01-12 | 24d | PDF↗ |
| Julie Johnson Rep | D-TX | Joint | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sale | $1.0K – $15.0K | 2025-12-18 | 2026-01-15 | 28d | PDF↗ |
| Julie Johnson Rep | D-TX | Joint | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sale (partial) | $1.0K – $15.0K | 2025-11-13 | 2025-12-11 | 28d | PDF↗ |
| Gilbert Ray Cisneros, Jr. Rep | D-CA | Self | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Purchase | $1.0K – $15.0K | 2025-11-12 | 2025-12-15 | 33d | PDF↗ |
| Gilbert Ray Cisneros, Jr. Rep | D-CA | Self | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sale (partial) | $1.0K – $15.0K | 2025-10-09 | 2025-11-18 | 40d | PDF↗ |
| Julie Johnson Rep | D-TX | Joint | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sale (partial) | $1.0K – $15.0K | 2025-08-14 | 2025-09-11 | 28d | PDF↗ |
| Virginia Foxx Rep | R-NC | Self | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sale | $1.0K – $15.0K | 2025-06-24 | 2025-07-03 | 9d | PDF↗ |
| Jefferson Shreve Rep | R-IN | Self | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sale | $15.0K – $50.0K | 2025-05-12 | 2025-06-22 | 41d | PDF↗ |
| Julia Letlow Rep | R-LA | Self | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sale | $1.0K – $15.0K | 2025-04-28 | 2026-01-13 | 260d LATE | PDF↗ |
| Julie Johnson Rep | D-TX | Joint | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sale | $1.0K – $15.0K | 2025-04-01 | 2025-05-14 | 43d | PDF↗ |
| Greg Landsman Rep | D-OH | Joint | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sale | $1.0K – $15.0K | 2025-03-27 | 2025-04-08 | 12d | PDF↗ |
| Julie Johnson Rep | D-TX | Joint | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Purchase | $1.0K – $15.0K | 2025-01-15 | 2025-02-12 | 28d | PDF↗ |
| Virginia Foxx Rep | R-NC | Self | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Purchase | $1.0K – $15.0K | 2024-12-06 | 2025-01-06 | 31d | PDF↗ |
| Val T. Hoyle Rep | D-OR | Spouse | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Purchase | $1.0K – $15.0K | 2024-10-29 | 2025-09-12 | 318d LATE | PDF↗ |
| Julia Letlow Rep | R-LA | Self | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Purchase | $1.0K – $15.0K | 2024-10-23 | 2026-01-13 | 447d LATE | PDF↗ |
| John James Rep | R-MI | Self | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sale | $1.0K – $15.0K | 2024-01-18 | 2024-09-02 | 228d LATE | PDF↗ |
| Rick Larsen Rep | D-WA | Self | BMY | Bristol-Myers Squibb Company (BMY) | Sale | $1.0K – $15.0K | 2024-01-09 | 2024-01-19 | 10d | PDF↗ |
| John James Rep | R-MI | Self | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Purchase | $1.0K – $15.0K | 2023-11-10 | 2024-09-02 | 297d LATE | PDF↗ |
| Greg Stanton Rep | D-AZ | Spouse | BMY | Bristol-Myers Squibb Company (BMY) | Sale | $1.0K – $15.0K | 2023-10-24 | 2023-11-09 | 16d | PDF↗ |
| Greg Stanton Rep | D-AZ | Spouse | BMY | Bristol-Myers Squibb Company (BMY) | Purchase | $1.0K – $15.0K | 2023-09-26 | 2023-11-09 | 44d | PDF↗ |
| Daniel S. Goldman Rep | D-NY | Self | BMY | Bristol-Myers Squibb Company (BMY) | Sale | $15.0K – $50.0K | 2023-07-12 | 2023-08-13 | 32d | PDF↗ |
| Daniel S. Goldman Rep | D-NY | Self | BMY | Bristol-Myers Squibb Company (BMY) [ST] ID Owner Asset | Purchase | $50.0K – $100.0K | 2023-04-10 | 2023-05-19 | 39d | PDF↗ |
| Daniel S. Goldman Rep | D-NY | Self | BMY | Bristol-Myers Squibb Company (BMY) | Sale | $1.0K – $15.0K | 2023-03-07 | 2023-04-17 | 41d | PDF↗ |
| Daniel S. Goldman Rep | D-NY | Self | BMY | Bristol-Myers Squibb Company (BMY) | Sale (partial) | $100.0K – $250.0K | 2023-03-06 | 2023-04-17 | 42d | PDF↗ |
| Nicholas V. Taylor Rep | ?-TX | Self | BMY | Bristol-Myers Squibb Company (BMY) | Sale (partial) | $100.0K – $250.0K | 2022-11-28 | 2022-12-26 | 28d | PDF↗ |
| Kathy Manning Rep | ?-NC | Spouse | BMY | Bristol-Myers Squibb Company (BMY) | Purchase | $1.0K – $15.0K | 2022-07-15 | 2022-08-10 | 26d | PDF↗ |
| John H. Rutherford Rep | R-FL | Self | BMY | Bristol-Myers Squibb Company (BMY) | Sale | $1.0K – $15.0K | 2022-03-16 | 2022-04-19 | 34d | PDF↗ |
| Carol D. Miller Rep | R-WV | Spouse | BMY | Bristol-Myers Squibb Company (BMY) | Sale (partial) | $15.0K – $50.0K | 2021-11-10 | 2022-09-02 | 296d LATE | PDF↗ |
| John A. Yarmuth Rep | ?-KY | Self | BMY | Bristol-Myers Squibb Company (BMY) | Purchase | $1.0K – $15.0K | 2021-09-23 | 2021-11-04 | 42d | PDF↗ |
| John A. Yarmuth Rep | ?-KY | Self | BMY | Bristol-Myers Squibb Company (BMY) | Purchase | $1.0K – $15.0K | 2021-09-22 | 2021-11-04 | 43d | PDF↗ |
| Thomas R. Suozzi Rep | D-NY | Self | BMY | 2000084729 Bristol-Myers Squibb Company (BMY) | Sale (partial) | $1.0K – $15.0K | 2021-06-07 | 2022-12-19 | 560d LATE | PDF↗ |
| Thomas R. Suozzi Rep | D-NY | Self | BMY | 2000084726 Bristol-Myers Squibb Company (BMY) | Sale (partial) | $1.0K – $15.0K | 2021-06-04 | 2022-12-19 | 563d LATE | PDF↗ |
| Rick Larsen Rep | D-WA | Self | BMY | Bristol-Myers Squibb Company (BMY) | Purchase | $1.0K – $15.0K | 2020-11-25 | 2023-05-26 | 912d LATE | PDF↗ |
| Thomas R. Suozzi Rep | D-NY | Self | BMY | Bristol-Myers Squibb Company (BMY) | Sale (partial) | $1.0K – $15.0K | 2020-07-30 | 2022-12-19 | 872d LATE | PDF↗ |
| Thomas R. Suozzi Rep | D-NY | Self | BMY | Bristol-Myers Squibb Company (BMY) | Sale (partial) | $1.0K – $15.0K | 2020-07-10 | 2022-12-19 | 892d LATE | PDF↗ |
| John H. Rutherford Rep | R-FL | Self | BMY | Bristol-Myers Squibb Company (BMY) | Purchase | $1.0K – $15.0K | 2020-06-21 | 2020-07-29 | 38d | PDF↗ |
| Mikie Sherrill Rep | ?-NJ | Self | BMY | Bristol-Myers Squibb Company (BMY) | Purchase | $1.0K – $15.0K | 2020-01-21 | 2020-02-19 | 29d | PDF↗ |
| Thomas R. Suozzi Rep | D-NY | Self | BMY | 2000084548 Bristol-Myers Squibb Company (BMY) | Sale | $15.0K – $50.0K | 2020-01-09 | 2022-12-19 | 1075d LATE | PDF↗ |
| Dean Phillips Rep | ?-MN | Self | BMY | Bristol-Myers squibb Company (BMY) [sT] | Purchase | $1.0K – $15.0K | 2019-11-21 | 2019-12-11 | 20d | PDF↗ |
| Dean Phillips Rep | ?-MN | Self | BMY | Bristol-Myers squibb Company (BMY) [sT] | Exchange | $1.0K – $15.0K | 2019-11-20 | 2019-12-11 | 21d | PDF↗ |
| Mikie Sherrill Rep | ?-NJ | Self | BMY | Bristol-Myers Squibb Company (BMY) | Purchase | $1.0K – $15.0K | 2019-07-25 | 2019-09-05 | 42d | PDF↗ |
| Thomas R. Suozzi Rep | D-NY | Self | BMY | 2000084402 Bristol-Myers Squibb Company (BMY) | Sale | $1.0K – $15.0K | 2019-04-08 | 2022-12-19 | 1351d LATE | PDF↗ |
| Thomas R. Suozzi Rep | D-NY | Self | BMY | Bristol-Myers Squibb Company (BMY) | Sale (partial) | $1.0K – $15.0K | 2019-03-29 | 2022-12-19 | 1361d LATE | PDF↗ |
| Carlos Curbelo Rep | ?-FL | Spouse | BMY | Bristol-Myers Squibb Company (BMY) | Sale | $1.0K – $15.0K | 2018-06-08 | 2018-08-02 | 55d LATE | PDF↗ |
| Thomas R. Suozzi Rep | D-NY | Self | BMY | Bristol-Myers Squibb Company (BMY) | Purchase | $1.0K – $15.0K | 2018-04-17 | 2022-12-19 | 1707d LATE | PDF↗ |
| Carlos Curbelo Rep | ?-FL | Spouse | BMY | Bristol-Myers Squibb Company (BMY) | Purchase | $1.0K – $15.0K | 2018-04-06 | 2018-08-02 | 118d LATE | PDF↗ |
| Alan S. Lowenthal Rep | ?-CA | Spouse | BMY | Bristol-Myers Squibb Company (BMY) FILINg STATuS: New SuBHOLdINg OF: Neuberger Berman - Tr | Sale | $15.0K – $50.0K | 2017-09-25 | 2017-10-10 | 15d | PDF↗ |
| John H. Rutherford Rep | R-FL | Self | BMY | Bristol-Myers Squibb Company (BMY) | Purchase | $1.0K – $15.0K | 2017-08-16 | 2018-08-20 | 369d LATE | PDF↗ |
Public-interest transparency data from official U.S. House Clerk STOCK Act disclosures (periodic transaction reports). Amounts are disclosed as ranges (e.g. $1,001–$15,000), not exact values, and members may report a trade up to 45 days after it happens — so recent activity can be missing. Trades flagged LATE were reported after 45 days. Scanned paper filings are linked but not parsed. Senate eFD ingest is not available yet.